HealthQuill FDA
The European Medicines Agency has recommended the stoppage of conditional marketing authorisationĀ for GSKā€™s Blenrep (belantamab mafodotin), a medicine used to treat cancer of the bone marrow.
Drugs Health Pharma

EMA recommends stopping sale of GSKā€™s blood cancer drug in EU

The European Medicines Agency has recommended the stoppage of conditional marketing authorisationĀ for GSKā€™s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.

Read More
Britainā€™s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German partner BioNTech SE that targets Omicron XBB.1.5 subvariant alone.
Drugs Health Pharma

Pfizer, BioNTechā€™s Covid-19 variant vaccine gets UK nod

HQ Team September 6, 2023: Britainā€™s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Drugs Health Pharma

Novo Nordiskā€™s weight-loss drug Wegovy enters the UK marketĀ 

HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.

Read More
Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering the recipientā€™s immune system to attack, scientists found.
Drugs Health Pharma

UCSF scientists mold a ā€˜bioreactorā€™ to replace dialysis

HQ Team September 2, 2023: Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering.

Read More
Rocheā€™s atezolizumab drug Tecentriq, to treat cancer, was approved by Britainā€™s Medicines and Healthcare Products Regulatory Agency.
Drugs Health Pharma

Rocheā€™s under-the-skin cancer injection gets Britainā€™s nodĀ 

HQ Team August 30, 2023: Rocheā€™s atezolizumab drug Tecentriq, to treat cancer, was approved by Britainā€™s Medicines and Healthcare Products Regulatory Agency. Tecentriq.

Read More
Takeda Pharmaceuticalā€™s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Pharma

First generic versions of Japanā€™s Takeda ADHD tabs gets FDA nod

HQ Team August 29, 2023: The US Food and Drug Administration has approved several first generics of Takeda Pharmaceutical subsidiary, Shire Plc’s Vyvanse.

Read More
Pfizer Incā€™s Abrysvo, a vaccine used in pregnant women to prevent lower respiratory tract infection caused by respiratory syncytial virus (RSV) in infants, was approved by the FDA.
Drugs Health Pharma

Pfizer gets FDA nod for infant respiratory tract infection vaccine

HQ Team August 22, 2023: Pfizer Incā€™s Abrysvo, a vaccine used in pregnant women to prevent lower respiratory tract infection caused by respiratory.

Read More
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Drugs Health Medical

Study finds FDA-prohibited substances in sports supplements

August 19, 2023: Researchers have found anomalies in the accuracy of ingredient labels and the presence of FDA-prohibited substances in a variety of.

Read More
Drugs Health Pharma

Franceā€™s Ipsen clears FDA hurdle for bone disorder drug Sohonos

HQ Team August 17, 2023: Ipsen, a French drugmaker, has received FDA approval for its Sohonos capsules to treat a rare bone disorder.

Read More
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More